GlassScriptPhysician profile
Salil Jitendra Patel
NPI 1083666366
$23,624.05
in general payments reported to CMS, 2019-2025
53 companies · $3,977 in 2025
The $3,977 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,928 · 2020: $2,354 · 2021: $2,289 · 2022: $4,647 · 2023: $3,815 · 2024: $3,614 · 2025: $3,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,406.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $4,073.38 | 2021-2025 | Impella |
| Penumbra, INC. | $3,520.89 | 2020-2025 | Indigo System, Penumbra System |
| Angiodynamics, INC. | $3,371.79 | 2019-2024 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $1,777.72 | 2019-2025 | Navitor, Triclip, Cardiomems |
| Boston Scientific Corporation | $1,497.34 | 2019-2025 | Rotapro, Opticross, Resonate El Icd Vr |
| Inari Medical, INC. | $1,275.28 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $1,160.75 | 2021-2025 | Hawkone, Onyx Frontier, Apollotm |
| Edwards Lifesciences Corporation | $901.25 | 2022-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Shockwave Medical, INC | $653.57 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $433.29 | 2025 | Flowtriever, Limflow System, Clottriever Bold Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $379.54 | 2019-2025 | Lifevest |
| Amgen INC. | $363.15 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $331.83 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $310.34 | 2019-2022 | |
| Teleflex LLC | $294.88 | 2022-2025 | Guideliner, Manta |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.